Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient.
1. The case is described of a 28-year old male with a diagnosis of Lesch-Nyhan syndrome. 2. Chronic treatment with the atypical neuroleptic risperidone at 4 mg daily has maintained a significant reduction in occurrence of self-mutilation.
Allen
S M
SM
North Mississippi Regional Center, Oxford, USA.
Rice
S N
SN
D000328:Adult; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D007926:Lesch-Nyhan Syndrome / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D018967:Risperidone / Q000627:therapeutic use*; D012652:Self Mutilation / Q000188:drug therapy* / Q000209:etiology
D018492:Dopamine Antagonists; D018967:Risperidone